Work

Randomized Phase 2 Study of Guadecitabine in Patients with HMA-Naive Higher Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Year: 2017

Type: article

Study design: Observational Study

Source: Leukemia Research

DOI: 10.1016/s0145-2126(17)30173-x

Authors: M.R. Savona, G. Garcia-Manero, G.J. Roboz, K.J. Walsh, P.L. Kropf, J.P. Issa, C.L. O’Connell, R. Tibes, K.W.L. Yee, W. Stock, S. Lunin, J.G. Berdeja, S. Naim, Y. Hao, M. Azab, H. Kantarjian

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2611779205

FWCI:

Cites:

Cited by:

Related to: 10